On withholding nutrition and hydration in the terminally ill: has palliative medicine gone too far? A reply.
Open Access
- 1 June 1995
- journal article
- research article
- Published by BMJ in Journal of Medical Ethics
- Vol. 21 (3) , 141-143
- https://doi.org/10.1136/jme.21.3.141
Abstract
Patients who are dying of cancer usually give up eating and then stop drinking. This raises ethical dilemmas about providing nutritional support and fluid replacement. The decision-making process should be based on a knowledge of the risks and benefits of giving or withholding treatments. There is no clear evidence that increased nutritional support or fluid therapy alters comfort, mental status or survival of patients who are dying. Rarely, subcutaneous fluid administration in the dying patient may be justified if the family remain distressed despite due consideration of the lack of medical benefit versus the risks. Some cancer patients who are not imminently dying become dehydrated from reversible conditions such as hypercalcaemia. This may mimic the effects of advanced cancer. These conditions should be sought and fluid replacement therapy should be given along with the specific treatments for the condition.Keywords
This publication has 8 references indexed in Scilit:
- On withholding nutrition and hydration in the terminally ill: has palliative medicine gone too far? A commentary.Journal of Medical Ethics, 1994
- On withholding nutrition and hydration in the terminally ill: has palliative medicine gone too far?Journal of Medical Ethics, 1994
- Palliative care ethics: non-provision of artificial nutrition and hydration to terminally ill sedated patients.Journal of Medical Ethics, 1994
- Dehydration symptoms of palliative care cancer patientsJournal of Pain and Symptom Management, 1993
- Terminal dehydration and intravenous fluidsThe Lancet, 1991
- PARENTERAL NUTRITION AND TUMOUR GROWTH IN THE PATIENT WITH COMPLICATED ABDOMINAL CANCERAnz Journal of Surgery, 1987
- TERMINAL DEHYDRATIONThe Lancet, 1984
- Total Parenteral Nutrition in the Cancer PatientNew England Journal of Medicine, 1981